JPWO2020047327A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020047327A5 JPWO2020047327A5 JP2021511583A JP2021511583A JPWO2020047327A5 JP WO2020047327 A5 JPWO2020047327 A5 JP WO2020047327A5 JP 2021511583 A JP2021511583 A JP 2021511583A JP 2021511583 A JP2021511583 A JP 2021511583A JP WO2020047327 A5 JPWO2020047327 A5 JP WO2020047327A5
- Authority
- JP
- Japan
- Prior art keywords
- chimeric protein
- amino acid
- acid sequence
- domain
- extracellular domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075517A JP2024096361A (ja) | 2018-08-29 | 2024-05-07 | Ｆｌｔ３ｌ系キメラタンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724596P | 2018-08-29 | 2018-08-29 | |
| US62/724,596 | 2018-08-29 | ||
| PCT/US2019/048922 WO2020047327A2 (en) | 2018-08-29 | 2019-08-29 | Flt3l-based chimeric proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075517A Division JP2024096361A (ja) | 2018-08-29 | 2024-05-07 | Ｆｌｔ３ｌ系キメラタンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512540A JP2022512540A (ja) | 2022-02-07 |
| JPWO2020047327A5 true JPWO2020047327A5 (https=) | 2022-09-06 |
| JP2022512540A5 JP2022512540A5 (https=) | 2022-09-06 |
Family
ID=69643788
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511583A Pending JP2022512540A (ja) | 2018-08-29 | 2019-08-29 | Ｆｌｔ３ｌ系キメラタンパク質 |
| JP2024075517A Withdrawn JP2024096361A (ja) | 2018-08-29 | 2024-05-07 | Ｆｌｔ３ｌ系キメラタンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075517A Withdrawn JP2024096361A (ja) | 2018-08-29 | 2024-05-07 | Ｆｌｔ３ｌ系キメラタンパク質 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240122983A1 (https=) |
| EP (1) | EP3843755A4 (https=) |
| JP (2) | JP2022512540A (https=) |
| CN (1) | CN112888711A (https=) |
| AU (1) | AU2019333175A1 (https=) |
| CA (1) | CA3109352A1 (https=) |
| IL (1) | IL281088A (https=) |
| MX (1) | MX2021002289A (https=) |
| WO (1) | WO2020047327A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20210687A (es) * | 2019-06-25 | 2022-03-03 | Gilead Sciences Inc | PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO |
| JP2023506501A (ja) * | 2019-12-16 | 2023-02-16 | ワシントン・ユニバーシティ | キメラ抗原受容体樹状細胞（ｃａｒ－ｄｃ）ならびにこれを作製および使用する方法 |
| WO2022089418A1 (zh) * | 2020-10-26 | 2022-05-05 | 信达生物制药(苏州)有限公司 | 重组截短FLT3配体与人抗体Fc的融合蛋白 |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK782002A3 (en) * | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| EP1276501B9 (en) * | 2000-04-25 | 2007-01-24 | Immunex Corporation | Method for treatment of tumors using photodynamic therapy |
| MXPA03003632A (es) * | 2000-10-24 | 2003-09-10 | Immunex Corp | Metodo para tratamiento de tumores usando terapia de combinacion. |
| CN101198621A (zh) * | 2005-01-25 | 2008-06-11 | 阿波罗生命科学有限公司 | 分子及其嵌合分子 |
| WO2014043215A1 (en) * | 2012-09-11 | 2014-03-20 | The Texas A&M University System | Bi-specifc diabodies for masking and targeting vaccines |
| RU2766200C1 (ru) * | 2015-10-01 | 2022-02-09 | Хит Байолоджикс, Инк. | Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков |
| JP6898325B2 (ja) * | 2015-12-08 | 2021-07-07 | ユニバーシティ−インダストリー・ファンデーション・ヨンセイ・ユニバーシティ | ＧＭ−ＣＳＦ遺伝子；Ｆｌｔ３Ｌ−ＴＲＡＩＬ融合遺伝子；ＴＧＦ−βの発現を抑制するｓｈＲＮＡ；およびＨＳＰ発現を抑制するｓｈＲＮＡを含む抗腫瘍組成物 |
-
2019
- 2019-08-29 WO PCT/US2019/048922 patent/WO2020047327A2/en not_active Ceased
- 2019-08-29 EP EP19854980.0A patent/EP3843755A4/en not_active Withdrawn
- 2019-08-29 JP JP2021511583A patent/JP2022512540A/ja active Pending
- 2019-08-29 MX MX2021002289A patent/MX2021002289A/es unknown
- 2019-08-29 AU AU2019333175A patent/AU2019333175A1/en active Pending
- 2019-08-29 CN CN201980068131.4A patent/CN112888711A/zh active Pending
- 2019-08-29 CA CA3109352A patent/CA3109352A1/en active Pending
-
2021
- 2021-02-24 IL IL281088A patent/IL281088A/en unknown
-
2023
- 2023-12-26 US US18/396,206 patent/US20240122983A1/en not_active Abandoned
-
2024
- 2024-05-07 JP JP2024075517A patent/JP2024096361A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7423684B2 (ja) | 免疫細胞を操作するための抗原提示足場 | |
| US20240374728A1 (en) | T Cell Modification | |
| CN113501884B (zh) | 靶向B7H3的全人源嵌合抗原受体、iNKT细胞及其用途 | |
| Liu et al. | The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component | |
| Wang et al. | Immune regulation by 4‐1BB and 4‐1BBL: complexities and challenges | |
| Nguyen et al. | RETRACTED: Cross-linking the B7 Family Molecule B7-DC Directly Activates Immune Functions of Dendritic Cells | |
| CN112673025B (zh) | 一种包含第三信号受体的嵌合抗原受体及其应用 | |
| CN107082812A (zh) | 一种恢复衰竭性免疫细胞功能的融合蛋白及其应用 | |
| JP2022512540A5 (https=) | ||
| EP3365434A1 (en) | Methods for culturing cells and kits and apparatus for same | |
| US7435585B2 (en) | Auto-stimulating cells and methods for making and using the same | |
| US6297052B1 (en) | B cell culture system comprising high density membrane bound CD40 ligand | |
| KR20230070256A (ko) | 이중특이성 재조합 단백질 및 이의 용도 | |
| JP2023521966A (ja) | 改変ｂ細胞及びその使用方法 | |
| WO2008118369A2 (en) | Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity | |
| WO2018058432A1 (zh) | 一种多基因重组嵌合抗原受体分子及其应用 | |
| WO2022171179A1 (zh) | 一种扩增增强子及其应用 | |
| CN113621077A (zh) | 一种tim-3/cd28融合蛋白及所述融合蛋白修饰的car-t细胞 | |
| JPWO2020047327A5 (https=) | ||
| WO2023142683A1 (zh) | 靶向巨细胞病毒抗原的tcr和表达其的t细胞及应用 | |
| CN108285493B (zh) | 一种恢复衰竭性免疫细胞功能的融合蛋白及其应用 | |
| WO2019243888A9 (en) | Compositions and methods for making engineered t cells | |
| Graham et al. | Targeting interferon-alpha to dendritic cells enhances a CD8+ T cell response to a human CD40-targeted cancer vaccine | |
| Miconnet et al. | A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response | |
| Li et al. | 4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo |